Certain Shares of StemRIM are subject to a Lock-Up Agreement Ending on 4-FEB-2020.
Details:
The seller Kensuke Tomita, sellers and company officers Toshihiko Yamazaki and Tsutomu Kanzaki, shareholders Katsuhito Tamai, Keiko Tamai, Toshiyuki Okubo, Osaka Bio Fund L.P., Akira Usui, Kohei Nishimaki, The Kato Memorial Bioscience Foundation, ECS LLC and JAIC-Bridge No. 2 Fund L.P., and Company stock acquisition rights owners and Company officers Koichi Yokota, Yoji Kuwatari, Hidefumi Yukimasa and Kazuyoshi Tsuda, promised SMBC Nikko Securities Inc. (hereafter, the lead manager) that no sale of common shares would be done without a prior written consent, during the period which starts on the underwriting contract signing date, and ends on February 4, 2020 (the 180th day after listing).